1. Home
  2. AXON vs TAK Comparison

AXON vs TAK Comparison

Compare AXON & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axon Enterprise Inc.

AXON

Axon Enterprise Inc.

HOLD

Current Price

$508.49

Market Cap

44.1B

Sector

Industrials

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$17.12

Market Cap

52.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXON
TAK
Founded
1993
1781
Country
United States
Japan
Employees
N/A
47455
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1B
52.4B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
AXON
TAK
Price
$508.49
$17.12
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$758.80
N/A
AVG Volume (30 Days)
1.1M
2.7M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
3.24%
EPS Growth
N/A
N/A
EPS
2.05
N/A
Revenue
$2,779,536,000.00
N/A
Revenue This Year
$31.50
$0.16
Revenue Next Year
$28.95
$1.22
P/E Ratio
$263.15
$41.25
Revenue Growth
33.47
N/A
52 Week Low
$339.01
$12.99
52 Week High
$885.92
$18.90

Technical Indicators

Market Signals
Indicator
AXON
TAK
Relative Strength Index (RSI) 47.80 66.84
Support Level $496.58 $15.88
Resistance Level $515.80 $18.86
Average True Range (ATR) 33.84 0.22
MACD -8.56 0.07
Stochastic Oscillator 12.77 92.91

Price Performance

Historical Comparison
AXON
TAK

About AXON Axon Enterprise Inc.

Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: